SEC Form 4 · accession 0001104659-17-021949

MusclePharm Corp · MSLP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

10% Owner

Period of report

Apr 4, 2017

Accepted (ET)

Apr 6, 2017 · 2:51 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001415684

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Apr 4, 2017	P	100	$2.112	A	2,029,981	D
Common Stock	Apr 4, 2017	P	100	$2.112	A	2,030,081	D
Common Stock	Apr 4, 2017	P	34,800	$2.12	A	2,064,881	D
Common Stock	Apr 4, 2017	P	762	$2.115	A	2,065,643	D
Common Stock	Apr 4, 2017	P	762	$2.115	A	2,066,405	D
Common Stock	Apr 4, 2017	P	762	$2.115	A	2,067,167	D
Common Stock	Apr 4, 2017	P	762	$2.1299	A	2,067,929	D
Common Stock	Apr 4, 2017	P	2,500	$2.14	A	2,070,429	D
Common Stock	Apr 4, 2017	P	152	$2.15	A	2,070,581	D
Common Stock	Apr 4, 2017	P	5,000	$2.145	A	2,075,581	D
Common Stock	Apr 5, 2017	P	41,900	$2.1496	A	2,117,481	D

No Table II lines on this filing.